Skip to main content
Equibles

GELS · Gelteq Ltd · Metrics

Track GELS — free

Use GELS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GELS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.38 0.00 (-0.63%)
Rebalance outlook locked
Market Cap
$4.08M
Shares
10.71M
Volume · Nov 12 24.91K Avg daily vol (3M) 2.81M

GELS metrics

48 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.38
Market cap
$4.08M

Price action

23 metrics
Price change (1W)
-16.4%
Price change (30D)
-15.4%
Price change (3M)
-34.5%
Price change (6M)
-15.6%
Price change (YTD)
-52.4%
Price change (1Y)
-64.1%
Trailing year
Price change (5Y)
—
52-week high
$1.53
52-week low
$0.38
Change from 52-week high
-75.1%
Change from 52-week low
+0.0%
Annualized volatility
229.3%
Annualized volatility (3M)
128.1%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
2.6
RSI (14D)
31.0
Price vs SMA 50
-29.5%
Price vs SMA 200
-39.7%
Avg volume (3M)
2.81M
Relative volume
0.0
Average dollar volume
$2.12M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
10.71M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.4
reciprocal yield 232.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-83.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
30.3%
Operating margin
-3,317.7%
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$6.36M
Net income (TTM)
−$3.41M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-27.5%
Return on assets
-20.6%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
−$3.30M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-2.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$6,235
Total assets
$13.42M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
$450,766
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
6
13F filer change QoQ
+1
Institutional ownership
1.0%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+52.3%
Holder tenure
2.2
Price vs estimated holder cost
-32.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
2.1%
Latest settlement · 2.1 days to cover
Days to cover
2.1d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1920092 CUSIP Q3978B109 13F (30d) 5 filings 5 filers Visit website Investor relations